
Meridian Bioscience VIVO
Land |
|
IPO-Jahr |
1986 |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBAL |
Anteile |
43.6 M |
Marktkapitalisierung |
$ 1.49 B |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Trinity Biotech plc
TRIB
|
$ 5.88 | 10.08 % | $ 2.11 B | Nasdaq Global Select Market | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | ||
|
National Research Corporation
NRC
|
$ 26.91 | 0.9 % | $ 602 M | Nasdaq Global Select Market | ||
|
Twist Bioscience Corporation
TWST
|
$ 132.17 | -2.35 % | $ 7.9 B | Nasdaq Global Select Market,SPB | ||
|
Organovo Holdings
ONVO
|
- | -2.3 % | $ 19.4 M | Nasdaq Capital Market | ||
|
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | ||
|
PerkinElmer
PKI
|
- | -0.91 % | $ 14.7 B | NYSE,SPB | ||
|
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Waters Corporation
WAT
|
$ 476.29 | -0.09 % | $ 28.4 B | NYSE,SPB | ||
|
Exagen
XGN
|
$ 5.26 | -25.92 % | $ 113 M | Nasdaq Global Market | ||
|
Celcuity
CELC
|
$ 67.13 | -4.11 % | $ 3.14 B | Nasdaq Global Select Market | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 370.89 | -0.25 % | $ 30.9 B | NYSE,SPB | ||
|
Lantheus Holdings
LNTH
|
$ 101.65 | 0.63 % | $ 6.86 B | Nasdaq Global Select Market,SPB | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Medpace Holdings
MEDP
|
$ 664.97 | -1.18 % | $ 19.2 B | Nasdaq Global Select Market,SPB | ||
|
Charles River Laboratories International
CRL
|
$ 346.21 | -2.02 % | $ 17.2 B | NYSE,SPB | ||
|
Mettler-Toledo International
MTD
|
$ 1 750.2 | -0.69 % | $ 36.1 B | NYSE,SPB | ||
|
Danaher Corporation
DHR
|
$ 236.19 | 0.46 % | $ 168 B | NYSE,SPB | ||
|
Koninklijke Philips N.V.
PHG
|
$ 30.39 | -1.32 % | $ 28.8 B | NYSE | ||
|
RadNet
RDNT
|
$ 77.91 | -0.6 % | $ 5.86 B | Nasdaq Global Select Market | ||
|
Senseonics Holdings
SENS
|
$ 10.05 | 2.55 % | $ 419 M | NYSE American | ||
|
Neuronetics
STIM
|
$ 2.01 | -7.8 % | $ 133 M | Nasdaq Global Select Market | ||
|
T2 Biosystems
TTOO
|
- | -39.35 % | $ 313 K | Nasdaq Global Select Market | ||
|
Thermo Fisher Scientific
TMO
|
$ 719.09 | -0.35 % | $ 271 B | NYSE,SPB | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Guardant Health
GH
|
$ 155.43 | -2.12 % | $ 19.5 B | Nasdaq Global Select Market,SPB | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Brainsway Ltd.
BWAY
|
$ 10.63 | -8.68 % | $ 361 M | Nasdaq Global Select Market | ||
|
VolitionRx Limited
VNRX
|
$ 0.19 | -6.2 % | $ 23.9 M | NYSE American | ||
|
Natera
NTRA
|
$ 311.81 | -1.92 % | $ 42.6 B | Nasdaq Global Select Market,SPB | ||
|
IQVIA Holdings
IQV
|
$ 275.46 | -1.21 % | $ 47.4 B | NYSE,SPB | ||
|
Agilent Technologies
A
|
$ 178.84 | -0.74 % | $ 50.8 B | NYSE,SPB | ||
|
Quotient Limited
QTNT
|
- | -11.32 % | $ 1.1 M | Nasdaq Global Select Market | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
Surmodics
SRDX
|
- | - | $ 608 M | Nasdaq Global Select Market,SPB | ||
|
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | ||
|
Syneos Health
SYNH
|
- | - | $ 4.46 B | Nasdaq Global Select Market,SPB | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Renalytix AI plc
RNLX
|
- | 5.66 % | $ 22.7 M | Nasdaq Global Market | ||
|
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market |